These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33964094)

  • 1. Insights into the skin microbiome of sickle cell disease leg ulcers.
    Byeon J; Blizinsky KD; Persaud A; Findley K; Lee JJ; Buscetta AJ; You S; Bittinger K; Minniti CP; Bonham VL; Grice EA
    Wound Repair Regen; 2021 Sep; 29(5):801-809. PubMed ID: 33964094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common, But Neglected: A Comprehensive Review of Leg Ulcers in Sickle Cell Disease.
    Sahu T; Verma HK; Ganguly S; Sinha M; Sinha R
    Adv Skin Wound Care; 2021 Aug; 34(8):423-431. PubMed ID: 34260420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leg Ulcers in Sickle-Cell Disease: Treatment Update.
    Monfort JB; Senet P
    Adv Wound Care (New Rochelle); 2020 Jun; 9(6):348-356. PubMed ID: 32286203
    [No Abstract]   [Full Text] [Related]  

  • 4. Healing of chronic sickle cell disease-associated foot and ankle wounds using transdermal continuous oxygen therapy.
    Massenburg BB; Himel HN
    J Wound Care; 2016 Feb; 25(2):S23-4, S26-7. PubMed ID: 26878371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of fetal microchimeric cells to maternal wound healing in sickle cell ulcers.
    Alkobtawi M; Sbeih M; Souaid K; Ngô QT; Nassar D; Arbes H; Guillet H; Habibi A; Bartolucci P; Castela M; Aractingi S; Oulès B
    Haematologica; 2023 Jul; 108(7):1920-1933. PubMed ID: 36373248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in the pathophysiology of leg ulcers in sickle cell disease.
    Catella J; Guillot N; Nader E; Skinner S; Poutrel S; Hot A; Connes P; Fromy B
    Br J Haematol; 2024 Jul; 205(1):61-70. PubMed ID: 38867511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recalcitrant chronic leg ulcer in a known sickle cell anaemia patient using honey and fresh hbaa red cell concentrate in a Nigerian secondary healthcare facility.
    Nwagu MU; Omokhua GI
    Ann Afr Med; 2020; 19(4):278-281. PubMed ID: 33243953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.
    Altman IA; Kleinfelder RE; Quigley JG; Ennis WJ; Minniti CP
    Int Wound J; 2016 Dec; 13(6):1315-1324. PubMed ID: 26537664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.
    Minniti CP; Delaney KM; Gorbach AM; Xu D; Lee CC; Malik N; Koroulakis A; Antalek M; Maivelett J; Peters-Lawrence M; Novelli EM; Lanzkron SM; Axelrod KC; Kato GJ
    Am J Hematol; 2014 Jan; 89(1):1-6. PubMed ID: 23963836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
    Tolu SS; Crouch A; Choi J; Gao Q; Reyes-Gil M; Ogu UO; Vinces G; Minniti CP
    Ann Hematol; 2022 Mar; 101(3):541-548. PubMed ID: 35039901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret.
    Umeh NI; Ajegba B; Buscetta AJ; Abdallah KE; Minniti CP; Bonham VL
    PLoS One; 2017; 12(10):e0186270. PubMed ID: 29045487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postural vasoconstriction and leg ulceration in homozygous sickle cell disease.
    Mohan JS; Marshall JM; Reid HL; Thomas PW; Serjeant GR
    Clin Sci (Lond); 1997 Feb; 92(2):153-8. PubMed ID: 9059316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group.
    Wethers DL; Ramirez GM; Koshy M; Steinberg MH; Phillips G; Siegel RS; Eckman JR; Prchal JT
    Blood; 1994 Sep; 84(6):1775-9. PubMed ID: 8080985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers.
    Méry L; Girot R; Aractingi S
    Dermatology; 2004; 208(2):135-7. PubMed ID: 15057003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease induces resistance to cutaneous carcinogenesis.
    Soutou B; Senet P; Lionnet F; Habibi A; Aractingi S
    Orphanet J Rare Dis; 2020 Mar; 15(1):66. PubMed ID: 32143660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients.
    Ayoola OO; Bolarinwa RA; Onakpoya UU; Adedeji TA; Onwuka CC; Idowu BM
    Blood Adv; 2018 Nov; 2(22):3112-3117. PubMed ID: 30455360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell leg ulcers: a frequently disabling complication and a marker of severity.
    Halabi-Tawil M; Lionnet F; Girot R; Bachmeyer C; Lévy PP; Aractingi S
    Br J Dermatol; 2008 Feb; 158(2):339-44. PubMed ID: 18047512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study.
    Senet P; Blas-Chatelain C; Levy P; Manea EM; Peschanski M; Mirault T; Stankovic-Stojanovic K; Debure C; Debbache K; Girot R; Bureau JM; Bachmeyer C; Baldeschi C; Galacteros F; Lionnet F; Gellen-Dautremer J
    Br J Dermatol; 2017 Jul; 177(1):206-211. PubMed ID: 27992062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell-based therapy for sickle cell leg ulcer: a pilot study.
    Meneses JV; Fortuna V; de Souza ES; Daltro GC; Meyer R; Minniti CP; Borojevic R
    Br J Haematol; 2016 Dec; 175(5):949-955. PubMed ID: 27604498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Microbial Communities on Wound Healing: A Review.
    Xu Z; Hsia HC
    Ann Plast Surg; 2018 Jul; 81(1):113-123. PubMed ID: 29746280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.